Impaired endogenous fibrinolysis at high shear using a point-of-care test in STEMI is associated with alterations in clot architecture

Impaired endogenous fibrinolysis is an adverse prognostic biomarker in acute coronary syndrome (ACS). Abnormally dense in vitro fibrin thrombi have been demonstrated in ACS patients and related to hypofibrinolysis using cumbersome, laboratory-based methods. We aimed to assess endogenous fibrinolysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Spinthakis, Nikolaos, Gue, Ying, Farag, Mohamed, Ren, Guogang, Srinivasan, Manivannan, Baydoun, Anwar, Gorog, Diana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439169/
https://www.ncbi.nlm.nih.gov/pubmed/30739303
http://dx.doi.org/10.1007/s11239-018-01799-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439169/
https://www.ncbi.nlm.nih.gov/pubmed/30739303
http://dx.doi.org/10.1007/s11239-018-01799-1

Ejemplares similares